During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiome Post sat down with Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, to learn more about the donor-based microbiome therapeutic products research and [...]
Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]
Asturias has 62 scientists among the most influential in the world. This has been revealed by the latest and prestigious Stanford ranking, which includes the 200,000 researchers -195,605 to be exact- most cited internationally in [...]
The TV show Conexión Asturias (RTPA) showcased Microviable Therapeutics activity in the microbiota field, currently focus on live biotherapeutic products (LBPs) development for Crohn´s disease and Autism Spectrum Disorder. […]
Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design a predictive model and open the possibility of designing treatments from Spain. […]
View more at “La Voz de Asturias” Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even storing the microbiota for future therapeutic uses. […]
El Comercio (Diario de Asturias), highlights Microviable’s activity in “the long-term isolation and storage of the microbiota under viable conditions, the analysis of its composition and, finally, the development of microbiome-based therapies. The first two business [...]
Microviable Therapeutics and its high scientific level deserve the attention of Spanish TV. #microbiota #storage for #therapy #personalized with your own microorganisms. […]
During the last week, the media had covered the exclusive service of intestinal microbiota storage that we offer. […]